Sarah Bakker

Molecular characterization of macrolide resistance mechanisms among <i>Streptococcus pneumoniae</i> and <i>Streptococcus pyogenes</i> isolated from the PROTEKT 1999-2000 study

David J. Farrell, Ian Morrissey, Sarah Bakker et al. · Journal of Antimicrobial Chemotherapy · 2002 · 155 citations · Full text

Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of <i>Streptococcus pneumoniae</i> from the PROTEKT 1999-2000 Study

David J. Farrell, Stephen Douthwaite, Ian Morrissey et al. · Antimicrobial Agents and Chemotherapy · 2003 · 99 citations · Full text

Klebsiella Pneumoniae, Pathology, Antibiotic Resistance +20

Molecular Epidemiology of Multiresistant <i>Streptococcus pneumoniae</i> with Both <i>erm</i> (B)- and <i>mef</i> (A)-Mediated Macrolide Resistance

David J. Farrell, Ian Morrissey, Sarah Bakker et al. · Journal of Clinical Microbiology · 2004 · 83 citations · Full text

In Vitro Activities of Telithromycin, Linezolid, and Quinupristin-Dalfopristin against <i>Streptococcus pneumoniae</i> with Macrolide Resistance Due to Ribosomal Mutations

David J. Farrell, Ian Morrissey, Sarah Bakker et al. · Antimicrobial Agents and Chemotherapy · 2004 · 78 citations · Full text

Global distribution of TEM-1 and ROB-1 β-lactamases in Haemophilus influenzae

David J. Farrell, Ian Morrissey, Sarah Bakker et al. · Journal of Antimicrobial Chemotherapy · 2005 · 76 citations